Navigation Links
Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect to Issuance and Sale of Stock
Date:6/11/2009

ed products and product candidates that are currently in development; grow product revenue through Cornerstone's specialty sales force which is focused on the respiratory and related markets; and maintain and strengthen the intellectual property position of Cornerstone's currently marketed products, newly acquired products and product candidates.

Important Information

Cornerstone has filed a proxy statement and other documents regarding the transaction described in this press release with the Securities and Exchange Commission. Security holders are urged to read the proxy statement carefully because it contains important information about Cornerstone and the transaction with Chiesi Farmaceutici SpA. A definitive proxy statement will be sent to stockholders of Cornerstone seeking their approval of the transaction. Investors and security holders may obtain a free copy of the definitive proxy statement (when available) and other documents filed by Cornerstone with the SEC at the SEC's website at www.sec.gov or from Cornerstone's website at www.crtx.com. The definitive proxy statement (when available) and other relevant documents may also be obtained free of cost by directing a request to Cornerstone Therapeutics Inc., 1255 Crescent Green Drive, Suite 250, Cary, North Carolina 27518, attention: Chief Financial Officer.

Participants in Solicitation

Cornerstone and its directors, members of management and other employees may be deemed to be participants in the solicitation of proxies from the stockholders of Cornerstone in connection with the transaction. Information about Cornerstone and its directors and executive officers can be found in Cornerstone's proxy statement and Annual Report on Form 10-K for the year ended December 31, 2008 previously filed with the SEC. Additional in
'/>"/>

SOURCE Cornerstone Therapeutics Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Carnegie Mellons Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future, March 25
2. Cornerstone Therapeutics, Inc. Taps Josh Franklin to Head Marketing Team
3. Cornerstone BioPharma Announces Completion of Merger with Critical Therapeutics
4. Cornerstone Therapeutics Announces New Board of Directors
5. OnCore(r) 9.0 Released: 'Top 5' Priorities and Collaborative Initiatives Cornerstones of Product Development
6. Cornerstone Therapeutics to Host First Quarter 2009 Conference Call
7. Cornerstone Therapeutics Announces $70 Million Strategic Transaction With Chiesi Farmaceutici SpA
8. Cornerstone Therapeutics Reports First Quarter 2009 Financial Results
9. Cornerstone Therapeutics Announces Management Change
10. TFAH Applauds Affordable Health Choices Act for Making Prevention a Cornerstone of Health Reform
11. Prime Therapeutics Receives TIPPS Certification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... -- For wounded U.S. servicemen and women ... D.C., the holidays can be a particularly difficult time. ... rely more than ever on the healing power of ... home just got easier for Walter Reed patients as ... will provide hundreds of minutes of holiday talk time ...
(Date:12/16/2009)... deadly, attack is long-term goal, researchers say , , ... a tool to predict whether a patient will suffer ... stroke. , "This is an important new tool because ... stroke soon after a first stroke are more likely ... of Massachusetts General Hospital and Harvard Medical School, said ...
(Date:12/16/2009)... advance that could help ease health and environmental concerns ... of technology for changing the behavior of nanoparticles in ... the environment. Their study was published in ACS, journal ... from the UK Centre for Ecology and Hydrology and ... production of nanoparticles particles less than 1/1000th the ...
(Date:12/16/2009)... Cost-Effective Care , ... Washington, D.C. (Vocus) December 16, ... ways to rein in runaway costs while providing care to all ... the ongoing discussion includes how to ensure patients equal access to ... (MDs) or osteopathy (DOs). In both the House and Senate ...
(Date:12/16/2009)... Substance Specific Neurological Stress Reduction Therapy or NSRTSM is found ... chronic conditions such as allergies, asthma, migraines, chronic fatigue and ... practices throughout the country are using this holistic therapy including ... ... Minneapolis, MN (Vocus) December 14, 2009 ...
Breaking Medicine News(10 mins):Health News:Verizon Wireless Donates $10,000 in Long-Distance Calling Cards to Soldiers at Walter Reed Hospital 2Health News:New Stroke Tool May Predict Early Recurrence 2Health News:Behavior modification could ease concerns about nanoparticles 2Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 2Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 3Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 4Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 5Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 2Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 3Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 4Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 5
... 29 categories of awards in the 2007 Association TRENDS ... Monthly Professional Society Magazine as well as the category ... will be honored at the Salute to Association Excellence ... JBS is the official publication of the Society for ...
... Technology,Inc. (Nasdaq: ALGN ), the inventor of ... and brackets, announced today that the,Company will report ... on,Tuesday, January 29, 2008, after the close of ... and First Call and will be available on,the ...
... (Nasdaq:,CRYO), a medical device company focused on the ... a European study of atrial,fibrillation patients treated with ... was to evaluate the role of atrial flutter ... of an ablation,strategy focused on isolating the pulmonary ...
... Calif., Jan. 4 DaVita Inc. (NYSE:,DVA) announced ... (,SKI,),have formed a wide-ranging partnership to provide dialysis ... disease education and research,in the greater Phoenix area. ... centers and programs designed to provide patients with,access ...
... Jan. 2 Roxane Laboratories, Inc.,announced today ... Application (ANDA),for Granisetron Hydrochloride Tablets, 1mg by ... is available in Unit Dose Blisters and ... pharmacies nationwide., (Logo: http://www.newscom.com/cgi-bin/prnh/20070410/CLTU122LOGO ...
... deal and free unique support channels, OWINGS MILLS, ... today announced that the Company is offering a special ... centers. Medifast is,offering Pure Weight Loss clients $55 Off ... at http://www.puremedifast.com or by calling 800-692-1791., ...
Other Medicine News:Health News:Align Technology to Announce Fourth Quarter and 2007 Year End Financial Results on January 29, 2008 2Health News:Align Technology to Announce Fourth Quarter and 2007 Year End Financial Results on January 29, 2008 3Health News:CryoCor Reports Publication in Circulation for Treatment of Atrial Fibrillation 2Health News:CryoCor Reports Publication in Circulation for Treatment of Atrial Fibrillation 3Health News:Roxane Laboratories, Inc. Announces the Launch of Granisetron Hydrochloride Tablets, 1mg 2Health News:Medifast Offers Stranded Pure Weight Loss Clients Unique Options 2Health News:Medifast Offers Stranded Pure Weight Loss Clients Unique Options 3
(Date:12/16/2009)... Scientists at,deCODE genetics, Inc. (Nasdaq: DCGN ... a version of a common single-letter variant in ... major impact on susceptibility to type 2,diabetes (T2D). ... only large, but unusual:,if an individual inherits it ... by more than 30% compared to those who ...
(Date:12/16/2009)... Wis., Dec. 16 EuroPharma, Inc. ... for the use of super absorbency BCM-95® ... EuroPharma formulations. The exclusive distribution territory ... health food store channel and professional channel, ... and clinics. BCM-95® is a highly ...
(Date:12/16/2009)... Inc. today announced the treatment of the first ... adhesive product, TissuGlu®. Initiation of the study marks ... the lead product toward clinical practice. ,, ... study to investigate the safety of TissuGlu and ... in abdominoplasty, or "tummy tuck," surgeries. The study ...
Breaking Medicine Technology:deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 2deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 3deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 4EuroPharma Exclusive Distributor of BCM-95 and BosPure 2EuroPharma Exclusive Distributor of BCM-95 and BosPure 3First Patient Treated in Clinical Study of Cohera Medical's TissuGlu(R) Surgical Adhesive 2First Patient Treated in Clinical Study of Cohera Medical's TissuGlu(R) Surgical Adhesive 3Rare genetic disease successfully reversed using stem cell transplantation 9972 1Rare genetic disease successfully reversed using stem cell transplantation 9972 2Rare genetic disease successfully reversed using stem cell transplantation 9972 3Micromet to Host Conference Call and Webcast to Discuss MT110 Data Presented at ECCO ESMO on September 22 2009 14130 1Micromet to Host Conference Call and Webcast to Discuss MT110 Data Presented at ECCO ESMO on September 22 2009 14130 2Micromet to Host Conference Call and Webcast to Discuss MT110 Data Presented at ECCO ESMO on September 22 2009 14130 3Trust for Americas Health Applauds HHS Announcement of Prevention and Wellness Fund of the American Recovery and Reinvestment Act 57556 1Trust for Americas Health Applauds HHS Announcement of Prevention and Wellness Fund of the American Recovery and Reinvestment Act 57556 2
... HARBIN, China, May 4 /PRNewswire-Asia-FirstCall/ -- China ... Medical" or "the Company") (Nasdaq: CSKI ), ... in the People,s Republic of China ("PRC"), today announced ... Sudden Cardiac Death (SCD) Early Examination Kit has been ...
... Australia, May 4 /PRNewswire-Asia-FirstCall/ -- Pharmaceutical,company Pharmaxis (ASX: PXS; ... positive,results of its recently completed international Phase III trial ... represents one of,the largest clinical trials conducted in cystic ... of the trial was to assess whether Bronchitol,improves lung ...
Other Medicine Technology:China Sky One Medical, Inc. Achieves Significant Breakthrough in Research for Sudden Cardiac Death (SCD) Early Examination Kit 2China Sky One Medical, Inc. Achieves Significant Breakthrough in Research for Sudden Cardiac Death (SCD) Early Examination Kit 3Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial 2Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial 3Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial 4Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial 5
NIDEK's US-1800 is an industry leader offering both combination pachymeter and ultrasound functionalities. The unit features and includes the latest IOL power calculation software, a touch screen pan...
... developed a minimally invasive cryocatheter to ... delivers a very high level of ... site precision, minimal tissue disruption, and ... ,Freezor is a flexible, single-use, minimally ...
Steerable catheter that is ideal for mapping unusual anatomy...
... specifically designed for use with our CARTO ... NAVI-STAR catheter houses a Biosense Webster sensor ... real time, exact location points from within ... information. The NAVI-STAR electro-anatomical navigation catheter is ...
Medicine Products: